Cite
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
MLA
Baden, Lindsey R., et al. “Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.” Annals of Internal Medicine, vol. 164, no. 5, Mar. 2016, pp. 313–22. EBSCOhost, https://doi.org/10.7326/M15-0880.
APA
Baden, L. R., Karita, E., Mutua, G., Bekker, L.-G., Gray, G., Page-Shipp, L., Walsh, S. R., Nyombayire, J., Anzala, O., Roux, S., Laher, F., Innes, C., Seaman, M. S., Cohen, Y. Z., Peter, L., Frahm, N., McElrath, M. J., Hayes, P., Swann, E., & Grunenberg, N. (2016). Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. Annals of Internal Medicine, 164(5), 313–322. https://doi.org/10.7326/M15-0880
Chicago
Baden, Lindsey R., Etienne Karita, Gaudensia Mutua, Linda-Gail Bekker, Glenda Gray, Liesl Page-Shipp, Stephen R. Walsh, et al. 2016. “Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.” Annals of Internal Medicine 164 (5): 313–22. doi:10.7326/M15-0880.